Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1983 Jun;52(3):655–664.

Maturation of human B lymphocytes--studies with a panel of monoclonal antibodies against membrane antigens.

H Zola, P J McNamara, H A Moore, I J Smart, D A Brooks, I G Beckman, J Bradley
PMCID: PMC1536031  PMID: 6191892

Abstract

The expression of six different membrane markers by cells of the human B lymphocyte lineage has been studied, using monoclonal antibodies. B cells representing various stages of differentiation/maturation have been examined, using normal cells, leukaemia cells, and continuous cell lines. The expression of the six markers has been compared with maturation stages defined by immunoglobulin expression. The HLA/beta 2-microglobulin complex is present throughout the B cell lineage, whilst the Ia (p28,33) marker is present from the earliest stage that can be attributed to the B lineage, but is lost during plasma cell differentiation. A marker detected by monoclonal antibody FMC 1 is present only on mature B lymphocytes, being absent from pre-B cells or plasma cells. FMC 7 detects an antigen found on a relatively mature subpopulation, whereas FMC 8 detects early as well as mature B cells. FMC 3 expression is found on a proportion of cells at any maturation stage, suggesting that expression of this marker is controlled by factors unrelated to maturation.

Full text

PDF
655

Images in this article

657Fig. 1
on p.657

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramson C. S., Kersey J. H., LeBien T. W. A monoclonal antibody (BA-1) reactive with cells of human B lymphocyte lineage. J Immunol. 1981 Jan;126(1):83–88. [PubMed] [Google Scholar]
  2. Ault K. A., Towle M. Human B lymphocyte subsets. I. IgG-bearing B cell response to pokeweed mitogen. J Exp Med. 1981 Feb 1;153(2):339–351. doi: 10.1084/jem.153.2.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bhan A. K., Nadler L. M., Stashenko P., McCluskey R. T., Schlossman S. F. Stages of B cell differentiation in human lymphoid tissue. J Exp Med. 1981 Sep 1;154(3):737–749. doi: 10.1084/jem.154.3.737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bodger M. P., Francis G. E., Delia D., Granger S. M., Janossy G. A monoclonal antibody specific for immature human hemopoietic cells and T lineage cells. J Immunol. 1981 Dec;127(6):2269–2274. [PubMed] [Google Scholar]
  5. Boyum A. Separation of blood leucocytes, granulocytes and lymphocytes. Tissue Antigens. 1974;4(4):269–274. [PubMed] [Google Scholar]
  6. Brooks D. A., Beckman I. G., Bradley J., McNamara P. J., Thomas M. E., Zola H. Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. IV. A monoclonal antibody reacting specifically with a subpopulation of human B lymphocytes. J Immunol. 1981 Apr;126(4):1373–1377. [PubMed] [Google Scholar]
  7. Brooks D. A., Beckman I., Bradley J., McNamara P. J., Thomas M. E., Zola H. Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. I. A hybridoma secreting antibody against a marker specific for human B lymphocytes. Clin Exp Immunol. 1980 Feb;39(2):477–485. [PMC free article] [PubMed] [Google Scholar]
  8. Brooks D. A., Bradley J., Zola H. A differentiation antigen expressed selectively by a proportion of human blood cells: detection with a monoclonal antibody. Pathology. 1982 Jan;14(1):5–11. doi: 10.3109/00313028209069036. [DOI] [PubMed] [Google Scholar]
  9. Catovsky D., Cherchi M., Brookss D., Bradely J., Zola H. Heterogeneity of B-cell leukemias demonstrated by the monoclonal antibody FMC7. Blood. 1981 Aug;58(2):406–408. [PubMed] [Google Scholar]
  10. Chechik B. E., Minowada J. Quantitation of human thymus-leukemia-associated antigen in established hematopoietic cell lines by radioimmunoassay. J Natl Cancer Inst. 1979 Sep;63(3):609–614. doi: 10.1093/jnci/63.3.609. [DOI] [PubMed] [Google Scholar]
  11. Cooper M. D. Pre-B cells; normal and abnormal development. J Clin Immunol. 1981 Apr;1(2):81–89. doi: 10.1007/BF00915383. [DOI] [PubMed] [Google Scholar]
  12. Galton D. A., Goldman J. M., Wiltshaw E., Catovsky D., Henry K., Goldenberg G. J. Prolymphocytic leukaemia. Br J Haematol. 1974 May;27(1):7–23. doi: 10.1111/j.1365-2141.1974.tb06769.x. [DOI] [PubMed] [Google Scholar]
  13. Greaves M. F. Recent progress in the immunological characterization of leukaemic cells. Blut. 1977 May;34(5):349–356. doi: 10.1007/BF00996074. [DOI] [PubMed] [Google Scholar]
  14. Halper J., Fu S. M., Wang C. Y., Winchester R., Kunkel H. G. Patterns of expression of human "Ia-like" antigens during the terminal stages of B cell development. J Immunol. 1978 May;120(5):1480–1484. [PubMed] [Google Scholar]
  15. Kersey J. H., LeBien T. W., Abramson C. S., Newman R., Sutherland R., Greaves M. P-24: a human leukemia-associated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody. J Exp Med. 1981 Mar 1;153(3):726–731. doi: 10.1084/jem.153.3.726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lok M. S., Koshiba H., Han T., Abe S., Minowada J., Sandberg A. A. Establishment and characterization of human B-lymphocytic lymphoma cell lines (BALM-3, -4 and -5); intraclonal variation in the B-cell differentiation stage. Int J Cancer. 1979 Nov 15;24(5):572–578. doi: 10.1002/ijc.2910240509. [DOI] [PubMed] [Google Scholar]
  17. Moore M. A., Broxmeyer H. E., Sheridan A. P., Meyers P. A., Jacobsen N., Winchester R. J. Continuous human bone marrow culture: Ia antigen characterization of probable pluripotential stem cells. Blood. 1980 Apr;55(4):682–690. [PubMed] [Google Scholar]
  18. Nadler L. M., Stashenko P., Hardy R., van Agthoven A., Terhorst C., Schlossman S. F. Characterization of a human B cell-specific antigen (B2) distinct from B1. J Immunol. 1981 May;126(5):1941–1947. [PubMed] [Google Scholar]
  19. Pearl E. R., Vogler L. B., Okos A. J., Crist W. M., Lawton A. R., 3rd, Cooper M. D. B lymphocyte precursors in human bone marrow: an analysis of normal individuals and patients with antibody-deficiency states. J Immunol. 1978 Apr;120(4):1169–1175. [PubMed] [Google Scholar]
  20. Stashenko P., Nadler L. M., Hardy R., Schlossman S. F. Characterization of a human B lymphocyte-specific antigen. J Immunol. 1980 Oct;125(4):1678–1685. [PubMed] [Google Scholar]
  21. Vogler L. B., Crist W. M., Bockman D. E., Pearl E. R., Lawton A. R., Cooper M. D. Pre-B-cell leukemia. A new phenotype of childhood lymphoblastic leukemia. N Engl J Med. 1978 Apr 20;298(16):872–878. doi: 10.1056/NEJM197804202981603. [DOI] [PubMed] [Google Scholar]
  22. Woda B. A., Racklin B., Rappaport H. Altered expression of histocompatibility antigens on "B" large cell lymphomas. Blood. 1981 Apr;57(4):802–804. [PubMed] [Google Scholar]
  23. Zola H., Beckman I. G., Bradley J., Brooks D. A., Kupa A., McNamara P. J., Smart I. J., Thomas M. E. Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. III. A marker defining a subpopulation of lymphocytes which cuts across the normal T-B-null classification. Immunology. 1980 Jun;40(2):143–150. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES